Ticker LaunchUplisting · INVO
INVO Fertility, Inc.
Formerly NAYA Biosciences, Inc.; INVO Bioscience, Inc.; EMY'S SALSA AJI DISTRIBUTION COMPANY, INC.
INVO Fertility, Inc. (INVO), already reporting to the SEC, moved up to a national exchange on Nov 13, 2020 with an offering at $3.20 per share raising $11.6M. Dentons advised the company and Dickinson Wright advised the underwriters.
INVO Fertility, Inc. is a medical device company in the assisted reproductive technology market. Its patented INVOcell is an intravaginal culture system used for in vivo incubation of eggs and sperm during fertilization and early embryo development, with FDA de novo classification and a CE Mark.
- Status
- Uplisting
- Ticker
- INVO
- Listed
- Nov 13, 2020
- Price
- $3.20
- Raised
- $11.6M
- Market cap at IPO price
- $27.5M
- First filed
- Dec 21, 2009
- Company counsel
- Dentons
- Underwriters' counsel
- Dickinson Wright
- Sector
- Healthcare
- Country / state
- FL
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
- Analyst notes on the filing
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Dec 21, 2009
- Latest amendment Nov 9, 2020
- Final prospectus (424B4) Nov 13, 2020
- All filings on EDGAR CIK 1417926
Other Healthcare uplistings in 2020
- Delcath Systems, Inc.DCTH · May 4, 2020 · $18.2M